Skip to playerSkip to main content
  • 5 hours ago
New global guidelines from the World Health Organization advise against using obesity drugs or GLP-1 injections like Mounjaro and Wegovy in children under 10. About 70 million children aged 5 to 9 are obese, with prevalence quadrupling since 1990 according to WHO estimates. The agency recommends focusing on healthy eating, exercise, and cautious use of digital tools for physical activity. WHO continues to evaluate emerging evidence on drug trials in younger children amid concerns about long-term effects. Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools.

Category

🗞
News
Transcript
00:00More than 70 million children, aged 5 to 9, are now obese worldwide.
00:04This figure has quadrupled since 1990, rising from 2% to 8% in that age group.
00:10Such a rise increases risks of serious health problems early in life, including type 2 diabetes.
00:17The World Health Organization, the UN's health agency, says obesity drugs like Munjaro and
00:22Wegovi should not be given to children under 10. These medicines are mostly licensed for older kids.
00:28But some doctors prescribe them off-label, and drug companies are testing them in children
00:33as young as 6. WHO recommends focusing on healthy eating and exercise instead of medicine or
00:40surgery for young children. WHO's director of nutrition, Luz de Regil, said,
00:44For children under 10, WHO does not recommend obesity medicines, bariatric surgery, or weight
00:51management devices. The agency says drug treatments might suit older children if lifestyle changes
00:56fail, and they are ready. WHO will keep reviewing the evidence as this field evolves to protect
01:03children's health. Disclosure. This video contains stock footage and content created or enhanced
01:08using AI-assisted tools.

Recommended